Strong Cortical and Spinal Cord Transduction After AAV7 and AAV9 Delivery into the Cerebrospinal Fluid of Nonhuman Primates
- 1 May 2013
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 24 (5), 526-532
- https://doi.org/10.1089/hum.2013.005
Abstract
The present study builds on previous work showing that infusion of adeno-associated virus type 9 (AAV9) into the cisterna magna (CM) of nonhuman primates resulted in widespread transduction throughout cortex and spinal cord. Transduction efficiency was severely limited, however, by the presence of circulating anti-AAV antibodies. Accordingly, we compared AAV9 to a related serotype, AAV7, which has a high capsid homology. CM infusion of either AAV7 or AAV9 directed high level of cell transduction with similar patterns of distribution throughout brain cortex and along the spinal cord. Dorsal root ganglia and corticospinal tracts were also transduced. Both astrocytes and neurons were transduced. Interestingly, little transduction was observed in peripheral organs. Our results indicate that intrathecal delivery of either AAV7 or AAV9 directs a robust and widespread cellular transduction in the central nervous system and other peripheral neural structures. Samaranch and colleagues compare the transduction profiles of AAV9-GFP and AAV7-GFP in nonhuman primates. They show that intrathecal delivery of either vector leads to equally high levels of cell transduction with similar patterns of distribution throughout the brain cortex and spinal cord, including the dorsal root ganglia and corticospinal tracts. Importantly, using this approach, they observe virtually no transduction of peripheral organs.Keywords
This publication has 19 references indexed in Scilit:
- Cerebral Infusion of AAV9 Vector-encoding Non-self Proteins Can Elicit Cell-mediated Immune ResponsesMolecular Therapy, 2013
- Over the barrier and through the blood: to CNS delivery we go.Cell Cycle, 2009
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated VirusesThe Journal of Infectious Diseases, 2009
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesNature Biotechnology, 2008
- Gene Therapy Using Adeno-Associated Virus VectorsClinical Microbiology Reviews, 2008
- Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic painProceedings of the National Academy of Sciences of the United States of America, 2008
- The “Perivascular Pump” Driven by Arterial Pulsation Is a Powerful Mechanism for the Distribution of Therapeutic Molecules within the BrainMolecular Therapy, 2006
- Controlling Neuropathic Pain by Adeno-Associated Virus Driven Production of the Anti-Inflammatory Cytokine, Interleukin-10Molecular Pain, 2005
- Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector.2003
- Adeno-associated virus vectors can be efficiently produced without helper virusGene Therapy, 1998